Characterization of Haemophilus ducreyi cdtA, cdtB, and cdtC mutants in in vitro and in vivo systems

被引:39
|
作者
Lewis, DA
Stevens, MK
Latimer, JL
Ward, CK
Deng, KP
Blick, R
Lumbley, SR
Ison, CA
Hansen, EJ
机构
[1] Univ London Imperial Coll Sci Technol & Med, Sch Med, Dept Genitourinary Med & Commincable Dis, London W2 1PG, England
[2] Univ London Imperial Coll Sci Technol & Med, Sch Med, Dept Microbiol, London W2 1PG, England
[3] Univ Texas, SW Med Ctr, Dept Microbiol, Dallas, TX 75235 USA
关键词
D O I
10.1128/IAI.69.9.5626-5634.2001
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Haemophilus ducreyi expresses a soluble cytolethal distending toxin (CDT) that is encoded by the cdtABC gene cluster and can be detected in culture supernatant fluid by its ability to kill HeLa cells. The cdtA, cdtB, and cdtC genes of H. ducreyi were cloned independently into plasmid vectors, and their encoded proteins expressed singly or in various combinations in an Escherichia coli background. All three gene products had to be expressed in order for E. coli-derived culture supernatant fluids to demonstrate cytotoxicity for HeLa cells. Isogenic H. ducreyi cdtA and cdtB mutants were constructed and used in combination with the wild-type parent strain and a previously described H. ducreyi cdtC mutant (M. K. Stevens, J. L. Latimer, S. R. Lumbley, C. K. Ward, L. D. Cope, T. Lagergard, and E. J. Hansen, Infect. Immun. 67:3900-3908, 1999) to determine the relative contributions of the CdtA, CdtB, and CdtC proteins to CDT activity. Expression of CdtA, CdtB, and CdtC appeared necessary for H. ducreyi-derived culture supernatant fluid to exhibit cytotoxicity for HeLa cells. Whole-cell sonicates and periplasmic extracts from the cdtB and cdtC mutants had no effect on HeLa cells, whereas these same fractions from a cdtA mutant had a very modest cytotoxic effect on these same human cells. CdtA appeared to be primarily associated with the H. ducreyi cell envelope, whereas both CdtB and CdtC were present primarily in the soluble fraction from sonicated cells. Both the cdtA mutant and the cdtB mutant were found to be fully virulent in the temperature-dependent rabbit model for experimental chancroid.
引用
收藏
页码:5626 / 5634
页数:9
相关论文
共 50 条
  • [31] Solid self-nanoemulsifying systems of olmesartan medoxomil: Formulation development, micromeritic characterization, in vitro and in vivo evaluation
    Beg, Sarwar
    Katare, O. P.
    Saini, Sumant
    Garg, Babita
    Khurana, Rajneet Kaur
    Singh, Bhupinder
    [J]. POWDER TECHNOLOGY, 2016, 294 : 93 - 104
  • [32] Ophthalmic delivery systems based on drug-polymer-polymer ionic ternary interaction: In vitro and in vivo characterization
    Sandri, G
    Bonferoni, MC
    Chetoni, P
    Rossi, S
    Ferrari, F
    Ronchi, C
    Caramella, C
    [J]. EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS, 2006, 62 (01) : 59 - 69
  • [33] Investigation of the Potential of Nebivolol Hydrochloride-Loaded Chitosomal Systems for Tissue Regeneration: In Vitro Characterization and In Vivo Assessment
    Elsherif, Noha Ibrahim
    Al-Mahallawi, Abdulaziz Mohsen
    Abdelkhalek, Abdelfattah Ahmed
    Shamma, Rehab Nabil
    [J]. PHARMACEUTICS, 2021, 13 (05)
  • [34] In vitro and in vivo characterization of equine herpesvirus type 1 (EHV-1) mutants devoid of the viral chemokine-binding glycoprotein G (gG)
    von Einem, Jens
    Smith, Patrick M.
    Van de Walle, Gerlinde R.
    O'Callaghan, Dennis J.
    Osterrieder, Nikolaus
    [J]. VIROLOGY, 2007, 362 (01) : 151 - 162
  • [35] SOTALOL CONTROLLED-RELEASE SYSTEMS FOR ARRHYTHMIAS - IN-VITRO CHARACTERIZATION, IN-VIVO DRUG DISPOSITION, AND ELECTROPHYSIOLOGIC EFFECTS
    LABHASETWAR, V
    UNDERWOOD, T
    GALLAGHER, M
    MURPHY, G
    LANGBERG, J
    LEVY, RJ
    [J]. JOURNAL OF PHARMACEUTICAL SCIENCES, 1994, 83 (02) : 156 - 164
  • [36] Formulation, characterization, in vitro and in vivo evaluation of castor oil based self-nano emulsifying levosulpiride delivery systems
    Poorani, G.
    Uppuluri, Spandana
    Uppuluri, Kiran Babu
    [J]. JOURNAL OF MICROENCAPSULATION, 2016, 33 (06) : 535 - 543
  • [37] Oral self-nanoemulsifying drug delivery systems for enhancing bioavailability and anticancer potential of fosfestrol: In vitro and in vivo characterization
    Galatage, Sunil T.
    Manjappa, Arehalli S.
    Bhagwat, Durgacharan A.
    Trivedi, Rahul
    Salawi, Ahmad
    Sabei, Fahad Y.
    Alsalhi, Abdullah
    [J]. EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS, 2023, 193 : 28 - 43
  • [38] Fabrication and Characterization of Surface Engineered Rifampicin Loaded Lipid Nanoparticulate Systems for the Potential Treatment of Tuberculosis: An In Vitro and In Vivo Evaluation
    Chokshi, Nimitt, V
    Rawal, Shruti
    Solanki, Dhruvi
    Gajjar, Saumitra
    Bora, Vivek
    Patel, Bhoomika M.
    Patel, Mayur M.
    [J]. JOURNAL OF PHARMACEUTICAL SCIENCES, 2021, 110 (05) : 2221 - 2232
  • [39] Drug testing and characterization using human-on-chip (HoC) systems: some thoughts on the application of in vitro-in vivo correlation
    Somayaji, Mahadevabharath R.
    Das, Debarun
    Przekwas, Andrzej J.
    [J]. DRUG DISCOVERY TODAY, 2018, 23 (09) : 1571 - 1573
  • [40] Establishment and characterization of equine fibroblast cell lines transformed in vivo and in vitro by BPV-1: Model systems for equine sarcoids
    Yuan, Z. Q.
    Gault, E. A.
    Gobeil, P.
    Nixon, C.
    Campo, M. S.
    Nasir, L.
    [J]. VIROLOGY, 2008, 373 (02) : 352 - 361